Advancing Early Infection Detection
Hear from patients and the Director of Medical Oncology at Roswell Park Cancer Center, Ellis Medicine.
Features of the AION TempShield™
Earlier Detection of Infection is Critical
Research consistently demonstrates that:
- Timely initiation of appropriate treatment significantly improves patient outcomes — each hour of delay in antibiotic administration for sepsis has been shown to increase mortality risk by 7.6%¹
- Delayed or inadequately treated infections are associated with increased risk of complications, prolonged hospitalization, and long-term health consequences — healthcare-associated infections add an estimated $28–33 billion annually in direct U.S. medical costs²
- Earlier detection and treatment of infection can result in meaningful cost savings for patients and healthcare systems — early sepsis identification before progression to organ failure leads to decreased severity, mortality, and costs³
¹ Journal of the American Medical Informatics Association, 2022 — Sepsis prediction, early detection, and identification using clinical text ² JAMA Internal Medicine, 2013 — Zimlichman et al., Health care-associated infections: a meta-analysis of costs and financial impact on the U.S. health care system ³ Critical Care Medicine, 2018 — Epidemiology and Costs of Sepsis in the United States
Who can benefit?
Cancer
Post Operation
Sepsis
Pediatrics
Long-Term Care
News
AI in Healthcare Podcast
“How Wearables Are Transforming Cancer Care”
Sam Barend, CEO of AION Biosystems, joins oncology thought leaders Dr. Doug Flora, Dr. Sanjay Juneja, and Dr. David Penberthy to discuss how TempShield is redefining the standard of care through early, proactive complication detection.
